The North America Cellular Health Screening Market would witness market growth of 8.5% CAGR during the forecast period (2022-2028).
Screening tests are used to determine a subset of the populace who should undergo additional testing to ascertain the existence or absence of disease, even if they are not thought of as diagnostic. To evaluate screening tests, researchers employ a variety of scientific techniques. They conduct studies to determine the validity of the test and observe whether a patient gains by beginning treatment sooner than later. This includes verifying which populations gain from early detection and treatment, and how the advantages stack up against the hazards.
There are numerous kinds of screening. One type of screening, for instance, would be administering the same tests to all infants (such as hearing exams). Opportunistic screening is a different type of screening in which a patient is offered confirmatory testing, like a blood pressure check, while they are in the office for a specific purpose. Anyone who meets the requirements for the test is encouraged to take a voluntary test as part of population-wide screening.
Frequently, the medical tests performed for screening reasons are inadequate for making a definitive diagnosis. Instead, a variety of tests are utilized to identify any abnormalities before more in-depth examinations with another testing. Testing for diseases using screening methods is not always done. Some screening exams are designed to find disease risk factors.
The focus of governments across regional countries on preventative healthcare has made way for the development of personalized medicine with the proper diagnosis. Rising patient awareness of Healthy Life Expectancy (HLE), measurement criteria for a country's wellbeing employed by WHO, has made an enormous stride in the home assessment segment. This has increased demand from households for screening assays. Moreover, the market is the United States is also growing as a result of the presence and expanding accessibility to oxidative stress testing and telomere and the higher adoption frequency of at-home testing choices.
The US market dominated the North America Cellular Health Screening Market by Country in 2021; thereby, achieving a market value of $1,163 million by 2028. The Canada market is experiencing a CAGR of 10.9% during (2022 - 2028). Additionally, The Mexico market would showcase a CAGR of 10% during (2022 - 2028).
Based on Sample Type, the market is segmented into Blood, Saliva, Serum, and Urine. Based on Collection Site, the market is segmented into Hospital, Diagnostic Labs, Home, and Office. Based on Test Type, the market is segmented into Single Test Panels and Multi-test Panels. Based on Single Test Panels Type, the market is segmented into Oxidative Stress Tests, Inflammation Tests, Telomere Tests, and Heavy Metals Tests. The report also covers geographical segmentation of Cellular Health Screening market. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Cellular Health Screening Market is Predict to reach $4.3 Billion by 2028, at a CAGR of 9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Quest Diagnostics Incorporated, OPKO Health, Inc., Laboratory Corporation of America Holdings, Genova Diagnostics, Telomere Diagnostics, Inc., Life Length, S.L., Repeat Diagnostics, Inc., SpectraCell Laboratories, Inc. (Beingmate Group Co. Ltd.), Cell Science Systems Corp. and Segterra, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Sample Type
By Collection Site
- Hospital
- Diagnostic Labs
- Home
- Office
By Test Type
- Single Test Panels
- Oxidative Stress Tests
- Inflammation Tests
- Telomere Tests
- Heavy Metals Tests
- Multi-test Panels
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
Companies Profiled
- Quest Diagnostics Incorporated
- OPKO Health, Inc.
- Laboratory Corporation of America Holdings
- Genova Diagnostics
- Telomere Diagnostics, Inc.
- Life Length, S.L.
- Repeat Diagnostics, Inc.
- SpectraCell Laboratories, Inc. (Beingmate Group Co. Ltd.)
- Cell Science Systems Corp.
- Segterra, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cellular Health Screening Market, by Sample Type
1.4.2 North America Cellular Health Screening Market, by Collection Site
1.4.3 North America Cellular Health Screening Market, by Test Type
1.4.4 North America Cellular Health Screening Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Cellular Health Screening Market by Sample Type
3.1 North America Blood Market by Country
3.2 North America Saliva Market by Country
3.3 North America Serum Market by Country
3.4 North America Urine Market by Country
Chapter 4. North America Cellular Health Screening Market by Collection Site
4.1 North America Hospital Market by Country
4.2 North America Diagnostic Labs Market by Country
4.3 North America Home Market by Country
4.4 North America Office Market by Country
Chapter 5. North America Cellular Health Screening Market by Test Type
5.1 North America Single Test Panels Market by Country
5.2 North America Cellular Health Screening Market by Single Test Panels Type
5.2.1 North America Oxidative Stress Tests Market by Country
5.2.2 North America Inflammation Tests Market by Country
5.2.3 North America Telomere Tests Market by Country
5.2.4 North America Heavy Metals Tests Market by Country
5.3 North America Multi-test Panels Market by Country
Chapter 6. North America Cellular Health Screening Market by Country
6.1 US Cellular Health Screening Market
6.1.1 US Cellular Health Screening Market by Sample Type
6.1.2 US Cellular Health Screening Market by Collection Site
6.1.3 US Cellular Health Screening Market by Test Type
6.1.3.1 US Cellular Health Screening Market by Single Test Panels Type
6.2 Canada Cellular Health Screening Market
6.2.1 Canada Cellular Health Screening Market by Sample Type
6.2.2 Canada Cellular Health Screening Market by Collection Site
6.2.3 Canada Cellular Health Screening Market by Test Type
6.2.3.1 Canada Cellular Health Screening Market by Single Test Panels Type
6.3 Mexico Cellular Health Screening Market
6.3.1 Mexico Cellular Health Screening Market by Sample Type
6.3.2 Mexico Cellular Health Screening Market by Collection Site
6.3.3 Mexico Cellular Health Screening Market by Test Type
6.3.3.1 Mexico Cellular Health Screening Market by Single Test Panels Type
6.4 Rest of North America Cellular Health Screening Market
6.4.1 Rest of North America Cellular Health Screening Market by Sample Type
6.4.2 Rest of North America Cellular Health Screening Market by Collection Site
6.4.3 Rest of North America Cellular Health Screening Market by Test Type
6.4.3.1 Rest of North America Cellular Health Screening Market by Single Test Panels Type
Chapter 7. Company Profiles
7.1 Quest Diagnostics Incorporated
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental Analysis
7.1.4 Recent strategies and developments:
7.1.4.1 Partnerships, Collaborations, and Agreements:
7.1.4.2 Product Launches and Product Expansions:
7.2 OPKO Health, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.3 Laboratory Corporation of America Holdings
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental Analysis
7.4 Genova Diagnostics
7.4.1 Company Overview
7.4.2 Recent strategies and developments:
7.4.2.1 Partnerships, Collaborations, and Agreements:
7.5 Telomere Diagnostics, Inc.
7.5.1 Company Overview
7.6 Life Length, S.L.
7.6.1 Company Overview
7.7 Repeat Diagnostics, Inc.
7.7.1 Company Overview
7.8 SpectraCell Laboratories, Inc. (Beingmate Group Co. Ltd.)
7.8.1 Company Overview
7.9 Cell Science Systems Corp.
7.9.1 Company Overview
7.10. Segterra, Inc. (INSIDETRACKER)
7.10.1 Company Overview
TABLE 1 North America Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 2 North America Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 3 North America Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 4 North America Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 5 North America Blood Market by Country, 2018 - 2021, USD Million
TABLE 6 North America Blood Market by Country, 2022 - 2028, USD Million
TABLE 7 North America Saliva Market by Country, 2018 - 2021, USD Million
TABLE 8 North America Saliva Market by Country, 2022 - 2028, USD Million
TABLE 9 North America Serum Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Serum Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Urine Market by Country, 2018 - 2021, USD Million
TABLE 12 North America Urine Market by Country, 2022 - 2028, USD Million
TABLE 13 North America Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 14 North America Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 15 North America Hospital Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Hospital Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Diagnostic Labs Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Diagnostic Labs Market by Country, 2022 - 2028, USD Million
TABLE 19 North America Home Market by Country, 2018 - 2021, USD Million
TABLE 20 North America Home Market by Country, 2022 - 2028, USD Million
TABLE 21 North America Office Market by Country, 2018 - 2021, USD Million
TABLE 22 North America Office Market by Country, 2022 - 2028, USD Million
TABLE 23 North America Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 24 North America Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 25 North America Single Test Panels Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Single Test Panels Market by Country, 2022 - 2028, USD Million
TABLE 27 North America Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 28 North America Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 29 North America Oxidative Stress Tests Market by Country, 2018 - 2021, USD Million
TABLE 30 North America Oxidative Stress Tests Market by Country, 2022 - 2028, USD Million
TABLE 31 North America Inflammation Tests Market by Country, 2018 - 2021, USD Million
TABLE 32 North America Inflammation Tests Market by Country, 2022 - 2028, USD Million
TABLE 33 North America Telomere Tests Market by Country, 2018 - 2021, USD Million
TABLE 34 North America Telomere Tests Market by Country, 2022 - 2028, USD Million
TABLE 35 North America Heavy Metals Tests Market by Country, 2018 - 2021, USD Million
TABLE 36 North America Heavy Metals Tests Market by Country, 2022 - 2028, USD Million
TABLE 37 North America Multi-test Panels Market by Country, 2018 - 2021, USD Million
TABLE 38 North America Multi-test Panels Market by Country, 2022 - 2028, USD Million
TABLE 39 North America Cellular Health Screening Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Cellular Health Screening Market by Country, 2022 - 2028, USD Million
TABLE 41 US Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 42 US Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 43 US Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 44 US Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 45 US Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 46 US Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 47 US Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 48 US Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 49 US Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 50 US Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 51 Canada Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 52 Canada Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 53 Canada Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 54 Canada Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 55 Canada Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 56 Canada Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 57 Canada Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 58 Canada Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 59 Canada Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 60 Canada Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 61 Mexico Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 62 Mexico Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 63 Mexico Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 64 Mexico Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 65 Mexico Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 66 Mexico Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 67 Mexico Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 68 Mexico Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 69 Mexico Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 70 Mexico Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 71 Rest of North America Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 72 Rest of North America Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 73 Rest of North America Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 74 Rest of North America Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 75 Rest of North America Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 76 Rest of North America Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 77 Rest of North America Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 78 Rest of North America Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 79 Rest of North America Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 80 Rest of North America Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 81 Key information – Quest Diagnostics Incorporated
TABLE 82 Key Information – OPKO Health, Inc.
TABLE 83 Key Information – Laboratory Corporation of America holdings
TABLE 84 Key Information – Genova Diagnostics
TABLE 85 Key Information – Telomere Diagnostics, Inc.
TABLE 86 Key Information – LIFE LENGTH, S.L.
TABLE 87 Key Information – Repeat Diagnostics, Inc.
TABLE 88 Key Information – SpectraCell Laboratories, Inc.
TABLE 89 Key Information – Cell Science Systems Corp.
TABLE 90 Key Information – SEGTERRA (INSIDETRACKER)
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Quest Diagnostics Incorporated